Tower Research Capital LLC (Trc) Prelude Therapeutics Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.29 Billion
  • Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 13,586 shares of PRLD stock, worth $12,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,586
Previous 10,376 30.94%
Holding current value
$12,499
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.64 - $1.39 $2,054 - $4,461
3,210 Added 30.94%
13,586 $10,000
Q4 2024

Feb 13, 2025
BUY
$0.8 - $2.04 $4,059 - $10,350
5,074 Added 95.7%
10,376 $13,000
Q3 2024

Nov 14, 2024
SELL
$2.07 - $6.37 $3,647 - $11,223
-1,762 Reduced 24.94%
5,302 $10,000
Q2 2024

Aug 13, 2024
BUY
$3.32 - $5.63 $12,340 - $20,926
3,717 Added 111.05%
7,064 $26,000
Q1 2024

May 15, 2024
SELL
$2.68 - $4.84 $1,728 - $3,121
-645 Reduced 16.16%
3,347 $15,000
Q4 2023

Feb 13, 2024
BUY
$1.69 - $4.37 $831 - $2,150
492 Added 14.06%
3,992 $17,000
Q3 2023

Nov 14, 2023
BUY
$2.74 - $4.79 $3,863 - $6,753
1,410 Added 67.46%
3,500 $10,000
Q2 2023

Aug 14, 2023
SELL
$4.45 - $8.12 $50,115 - $91,447
-11,262 Reduced 84.35%
2,090 $9,000
Q1 2023

May 09, 2023
BUY
$4.58 - $7.34 $44,975 - $72,078
9,820 Added 278.03%
13,352 $76,000
Q4 2022

Feb 10, 2023
BUY
$4.61 - $8.5 $10,501 - $19,363
2,278 Added 181.66%
3,532 $21,000
Q3 2022

Nov 10, 2022
SELL
$5.0 - $8.82 $13,850 - $24,431
-2,770 Reduced 68.84%
1,254 $9,000
Q2 2022

Aug 15, 2022
BUY
$4.0 - $7.55 $6,756 - $12,751
1,689 Added 72.33%
4,024 $21,000
Q1 2022

May 12, 2022
SELL
$6.9 - $13.22 $20,596 - $39,461
-2,985 Reduced 56.11%
2,335 $16,000
Q4 2021

Feb 14, 2022
BUY
$11.89 - $31.74 $21,651 - $57,798
1,821 Added 52.04%
5,320 $66,000
Q3 2021

Nov 15, 2021
BUY
$25.78 - $38.65 $62,748 - $94,074
2,434 Added 228.54%
3,499 $109,000
Q2 2021

Aug 16, 2021
SELL
$28.63 - $44.3 $49,816 - $77,082
-1,740 Reduced 62.03%
1,065 $31,000
Q1 2021

May 17, 2021
BUY
$39.27 - $91.68 $102,102 - $238,368
2,600 Added 1268.29%
2,805 $122,000
Q4 2020

Feb 16, 2021
BUY
$28.81 - $88.94 $5,906 - $18,232
205 New
205 $15,000

Others Institutions Holding PRLD

# of Institutions
56
Shares Held
28.3M
Call Options Held
23.9K
Put Options Held
0
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $33.5M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email